Suchergebnisse - "Lee, Yena"

PubPharm (17)

1

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

enthalten in: Journal of psychopharmacology (Oxford, England) | 2023

von Rashidian, H. | Subramaniapillai, M. | Park, C. | +12

2

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report : Serotonergic Psychedelic Treatments for Major Depressive Disorder

enthalten in: Canadian journal of psychiatry. Revue canadienne de psychiatrie | 2023

von Rosenblat, J. | Husain, M. | Lee, Y. | +18

3

Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation

enthalten in: CNS spectrums | 2022

von Rodrigues, N. | Siegel, A. | Lipsitz, O. | +13

4

Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?

enthalten in: Journal of sleep research | 2022

von Rodrigues, N. | McIntyre, R. | Lipsitz, O. | +13

5

Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression : A Case Series

enthalten in: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry | 2021

von Lipsitz, O. | Di Vincenzo, J. | Rodrigues, N. | +12

CommentIn: Am J Geriatr Psychiatry. 2021 Sep;29(9):914-916. - PMID 33509675

6

Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder : a systematic review and network meta-analysis

enthalten in: CNS spectrums | 2021

von Cao, B. | Xu, L. | Chen, Y. | +7

7

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety : Results from the Canadian Rapid Treatment Center of Excellence

enthalten in: Journal of psychopharmacology (Oxford, England) | 2021

von McIntyre, R. | Rodrigues, N. | Lipsitz, O. | +10

8

The emerging role of psilocybin and MDMA in the treatment of mental illness

enthalten in: Expert review of neurotherapeutics | 2020

von Gill, H. | Gill, B. | Chen-Li, D. | +11

9

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder : results from the Canadian rapid treatment center of excellence

enthalten in: Expert opinion on drug safety | 2020

von Rodrigues, N. | McIntyre, R. | Lipsitz, O. | +11

ErratumIn: Expert Opin Drug Saf. 2020 Jul 7;:1. - PMID 32633685

10

Parsing metabolic heterogeneity in mood disorders : A hypothesis-driven cluster analysis of glucose and insulin abnormalities

enthalten in: Bipolar disorders | 2020

von Mansur, R. | Lee, Y. | Subramaniapillai, M. | +3